GLUTRONICS(TM) Appoints Brad Boruk as Co-Chief Executive Officer

GLUTRONICS(TM) Appoints Brad Boruk as Co-Chief Executive Officer

Monday, 18 May 2026 09:55 AM

Topic: 

Company Update

GLUTRONICS™ is proud to announce: Appoints Brad Boruk as Co-Chief Executive Officer

DALLAS, TX / ACCESS Newswire / May 18, 2026 / GLUTRONICS™, a medical technology startup focused on non-invasive glucose monitoring, today announced the appointment of Brad Boruk as Co-Chief Executive Officer. Boruk will serve alongside Co-CEO Dr. Hoon Kim, who continues to lead the company's technology development and research initiatives. The appointment reflects the company's intent to expand its commercial and strategic capabilities as it advances its technology toward potential future commercialization.

Company Overview

GLUTRONICS™ is developing non-invasive glucose monitoring technology designed to provide metabolic health data without traditional finger-prick testing. The company's technology is currently in development and has not been cleared or approved by the FDA or any other regulatory authority. GLUTRONICS™ believes its approach has the potential to contribute to the evolution of how glucose levels are monitored, though significant development, testing, and regulatory milestones remain before any commercial product could be available.

Role and Responsibilities

As Co-CEO, Boruk will focus on business development, strategic partnerships, and commercialization planning, including:

  • Evaluating potential licensing and distribution relationships

  • Exploring international manufacturing partnerships

  • Supporting intellectual property strategy

  • Coordinating the company's FDA regulatory pathway

  • Assessing opportunities for integration with wearable health technology platforms

Dr. Kim will continue to oversee the company's research and development efforts, technical team, and product engineering.

"We see significant long-term potential in non-invasive glucose monitoring technology," said Boruk. "My focus will be on building the strategic relationships and commercial infrastructure needed to support GLUTRONICS™ as it works toward bringing its technology to market."

Market Context

The global market for glucose monitoring and metabolic health technology continues to grow, driven in part by increasing demand for less invasive monitoring alternatives, remote patient monitoring solutions, and wearable health technologies. GLUTRONICS™ believes these trends may create future opportunities for its technology, subject to successful development, regulatory clearance, and commercial viability.

Current Status

GLUTRONICS™ is currently in the development stage and is evaluating potential strategic relationships with manufacturing, distribution, and technology partners as part of its long-term planning. The company has not commenced commercial operations and its technology remains subject to further development and regulatory review.

Media Inquiries

Brad Boruk Co-Chief Executive Officer, GLUTRONICS™
Email: [email protected] Phone: (469) 964-6699

About GLUTRONICS™

GLUTRONICS™ is a development-stage medical technology company working on non-invasive glucose monitoring solutions and wearable healthcare technologies. The company's products are not currently available for commercial sale.

Regulatory Disclaimer

The glucose monitoring technology described in this press release has not been cleared or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. The product is currently in development and is not available for commercial sale. No claims are made herein regarding the diagnostic, therapeutic, or medical efficacy of the technology.

This press release contains forward-looking statements, including statements regarding the company's technology, business strategy, anticipated partnerships, regulatory plans, and commercialization timeline. These statements are based on current expectations and assumptions and involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. GLUTRONICS undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

GLUTRONICS™ is a trademark of GLUTRONICS. All other trademarks referenced herein are the property of their respective owners.

SOURCE: GluTronics LLC